Trials / Terminated
TerminatedNCT00856817
Heme Oxygenase (HO) Activity and Adenosine Induced Vasodilation
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 6 (estimated)
- Sponsor
- Radboud University Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine whether heme oxygenase 1 induction by heme arginate treatment is of influence on adenosine induced vasodilation in healthy individuals.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | L-arginine + heme arginate | L-arginine first, heme arginate second three day treatment |
| DRUG | Heme arginate + L-arginine | Heme arginate first, L-arginine second three day treatment |
Timeline
- Start date
- 2009-03-01
- First posted
- 2009-03-06
- Last updated
- 2011-08-11
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT00856817. Inclusion in this directory is not an endorsement.